Description
Supports a clinical diagnosis of Alzheimer disease (AD) in symptomatic individuals. Use for AD risk assessment only. Genetic counseling and informed consent are strongly recommended prior to ordering and post test to discuss results.
Test code(s)
BMG-301
TAT
5 business days
Method
Polymerase chain reaction (PCR)
Accepted Sample requirements
EDTA Blood, DNA